Literature DB >> 19102707

Setting future standards for KRAS testing in colorectal cancer.

Han van Krieken, Jolien Tol.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19102707     DOI： 10.2217/14622416.10.1.1

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN： 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  9 in total

1.  External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds.

Authors:  Ellen Bellon; Marjolijn J L Ligtenberg; Sabine Tejpar; Karen Cox; Gert de Hertogh; Karin de Stricker; Anders Edsjö; Vassilis Gorgoulis; Gerald Höfler; Andreas Jung; Athanassios Kotsinas; Pierre Laurent-Puig; Fernando López-Ríos; Tine Plato Hansen; Etienne Rouleau; Peter Vandenberghe; Johan J M van Krieken; Elisabeth Dequeker
Journal:  Oncologist       Date:  2011-03-26

2.  Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme.

Authors:  Elisabeth Dequeker; Marjolijn J L Ligtenberg; Sara Vander Borght; Johan H J M van Krieken
Journal:  Virchows Arch       Date:  2011-06-24       Impact factor: 4.064

3.  Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours.

Authors:  S Weidlich; K Walsh; D Crowther; M E Burczynski; G Feuerstein; F A Carey; R J C Steele; C R Wolf; G Miele; G Smith
Journal:  Br J Cancer       Date:  2011-06-28       Impact factor: 7.640

4.  Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours - implications for personalised cancer medicine.

Authors:  G Smith; R Bounds; H Wolf; R J C Steele; F A Carey; C R Wolf
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

5.  Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.

Authors:  Alexandre Harlé; Benoit Busser; Marie Rouyer; Valentin Harter; Pascal Genin; Agnès Leroux; Jean-Louis Merlin
Journal:  Virchows Arch       Date:  2013-02-12       Impact factor: 4.064

6.  A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens.

Authors:  D Gonzalez de Castro; B Angulo; B Gomez; D Mair; R Martinez; A Suarez-Gauthier; F Shieh; M Velez; V H Brophy; H J Lawrence; F Lopez-Rios
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

7.  Analytical performance of a PCR assay for the detection of KRAS mutations (codons 12/13 and 61) in formalin-fixed paraffin-embedded tissue samples of colorectal carcinoma.

Authors:  Sung Lee; Victoria H Brophy; Jianli Cao; Margot Velez; Corey Hoeppner; Stephen Soviero; H Jeffrey Lawrence
Journal:  Virchows Arch       Date:  2011-12-16       Impact factor: 4.064

Review 8.  Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status.

Authors:  Marc Peeters; Meinolf Karthaus; Fernando Rivera; Jan-Henrik Terwey; Jean-Yves Douillard
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

9.  Optimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer.

Authors:  Anne-Sophie Chretien; Alexandre Harlé; Magali Meyer-Lefebvre; Marie Rouyer; Marie Husson; Carole Ramacci; Valentin Harter; Pascal Genin; Agnès Leroux; Jean-Louis Merlin
Journal:  Cancer Med       Date:  2013-02-03       Impact factor: 4.452
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.